The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates

BMC Musculoskeletal Disorders

Volumn 13, Issue , 2012, Pages

  Zintzaras, Elias ^a,b   Papathanasiou, Afroditi A ^a   Ziogas, Dimitrios C ^c   Voulgarelis, Michael ^d  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Anti CCP2; Anti cyclic citrullinated peptide 2; Quality, Sensitivity; Rheumatoid arthritis; Specificity Meta analysis

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ARTICLE; ASSAY; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; METHODOLOGY; REFERENCE VALUE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; HUMANS; IMMUNOLOGIC TESTS; PEPTIDES, CYCLIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84862624173     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-13-113     Document Type: Article

References (36)

1. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Zintzaras E, Voulgarelis M, Moutsopoulos HM, Arch Intern Med 2005 165 2337 2344 10.1001/archinte.165.20.2337 16287762 (Pubitemid 41640845)
2. Rheumatoid arthritis. Lee DM, Weinblatt ME, Lancet 2001 358 903 911 10.1016/S0140-6736(01)06075-5 11567728 (Pubitemid 32900579)
3. Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens. Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM, Clin Ther 2008 30 1939 1955 10.1016/j.clinthera.2008.11.007 19108784
4. Rheumatoid arthritis-classification and epidemiology. MacGregor AJ, Silman AJ, Rheumatology Mosby, London 2 2000
5. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. Arthritis Rheum 1988 31 315 324 10.1002/art.1780310302 3358796 (Pubitemid 18091653)
6. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al. Ann Rheum Dis 2010 69 1580 1588 10.1136/ard.2010.138461 20699241
7. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Coenen D, Verschueren P, Westhovens R, Bossuyt X, Clin Chem 2007 53 498 504 10.1373/clinchem.2006.078063 17259232 (Pubitemid 46447947)
8. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A, Plischke H, Kellner H, Gruber R, Ann N Y Acad Sci 2005 1050 295 303 10.1196/annals.1313.031 16014545 (Pubitemid 41129447)
9. The devil in the details: the emerging role of anticitrulline autoimmunity in rheumatoid arthritis. van Gaalen F, Ioan-Facsinay A, Huizinga TW, Toes RE, J Immunol 2005 175 5575 5580 16237041 (Pubitemid 41508033)
10. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. De Rycke L, Peene I, Hoffman IE, Kruithof E, Union A, Meheus L, Lebeer K, Wyns B, Vincent C, Mielants H, et al. Ann Rheum Dis 2004 63 1587 1593 10.1136/ard.2003.017574 15547083 (Pubitemid 39573686)
11. Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis. Kudo-Tanaka E, Ohshima S, Ishii M, Mima T, Matsushita M, Azuma N, Harada Y, Katada Y, Ikeue H, Umeshita-Sasai M, et al. Clin Rheumatol 2007 26 1627 1633 10.1007/s10067-007-0558-5 17286215
12. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X, Jia R, Zhao J, Li Z, J Rheumatol 2009 36 1136 1142 10.3899/jrheum.080796 19447936
13. Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis. Whiting PF, Smidt N, Sterne JA, Harbord R, Burton A, Burke M, Beynon R, Ben-Shlomo Y, Axford J, Dieppe P, Ann Intern Med 2010 152 456 464 W155-466 20368651
14. A framework for clinical evaluation of diagnostic technologies. Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M, CMAJ 1986 134 587 594 3512062 (Pubitemid 16099651)
15. The efficacy of diagnostic imaging. Fryback DG, Thornbury JR, Med Decis Making 1991 11 88 94 10.1177/0272989X9101100203 1907710
16. Disease, level of impact, and quality of research methods. Three dimensions of clinical efficacy assessment applied to magnetic resonance imaging. Kent DL, Larson EB, Invest Radiol 1992 27 245 254 10.1097/00004424- 199203000-00014 1551777
17. Peripheral arterial disease: meta-analysis of the diagnostic performance of MR angiography. Nelemans PJ, Leiner T, de Vet HC, van Engelshoven JM, Radiology 2000 217 105 114 11012430 (Pubitemid 33097585)
18. An approach to therapeutic trials in rheumatology: the foundation for applied rheumatology research. De Vries E, Breedveld FC, Br J Rheumatol 1996 35 1000 1001 10.1093/rheumatology/35.10.1000 8883440 (Pubitemid 26348441)
19. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D, de Vet HC, Ann Intern Med 2003 138 40 44 12513043 (Pubitemid 36232093)
20. Use of methodological standards in diagnostic test research. Getting better but still not good. Reid MC, Lachs MS, Feinstein AR, JAMA 1995 274 645 651 10.1001/jama.1995.03530080061042 7637146
21. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG, Ann Intern Med 2003 138 1 W12 12513067
22. STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK and CONSORT: for whom does the guideline toll? Vandenbroucke JP, J Clin Epidemiol 2009 62 594 596 10.1016/j.jclinepi.2008.12. 003 19181482
23. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J, BMC Med Res Meth 2003 3 25 10.1186/1471-2288-3-25
24. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH, J Clin Epidemiol 2005 58 982 990 10.1016/j.jclinepi.2005.02.022 16168343 (Pubitemid 41316441)
25. A unification of models for meta-analysis of diagnostic accuracy studies. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA, Biostatistics 2007 8 239 251 16698768 (Pubitemid 46569586)
26. Metandi: Meta-analysis of diagnostic accuracy using hierarchical logistic regression. Harbord R, Whiting P, Stata J 2009 9 211 229
27. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, Saigo K, Morinobu A, Koshiba M, Kuntz KM, et al. Ann Intern Med 2007 146 797 808 17548411 (Pubitemid 351650500)
28. Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards. Fontela PS, Pant Pai N, Schiller I, Dendukuri N, Ramsay A, Pai M, PLoS One 2009 4 7753 10.1371/journal.pone.0007753 19915664
29. Quality reporting of endoscopic diagnostic studies in gastrointestinal journals: where do we stand on the use of the STARD and CONSORT statements? Areia M, Soares M, Dinis-Ribeiro M, Endoscopy 2010 42 138 147 10.1055/s-0029-1243846 20140830
30. Juvenile idiopathic arthritis of peripheral joints: quality of reporting of diagnostic accuracy of conventional MRI. Miller E, Roposch A, Uleryk E, Doria AS, Acad Radiol 2009 16 739 757 10.1016/j.acra.2009.01.012 19427982
31. The quality of reporting of diagnostic accuracy studies in diabetic retinopathy screening: a systematic review. Zafar A, Khan GI, Siddiqui MA, Clin Exp Ophthalmol 2008 36 537 542 10.1111/j.1442-9071.2008.01826.x
32. Assessing the quality of glucose monitor studies: a critical evaluation of published reports. Mahoney J, Ellison J, Clin Chem 2007 53 1122 1128 10.1373/clinchem.2006.083493 17478560 (Pubitemid 46867530)
33. The quality of reporting of diagnostic accuracy studies of optical coherence tomography in glaucoma. Johnson ZK, Siddiqui MA, Azuara-Blanco A, Ophthalmology 2007 114 1607 1612 10.1016/j.ophtha.2006.11.036 17434589 (Pubitemid 47332663)
34. Developmental dysplasia of the hip: quality of reporting of diagnostic accuracy for US. Roposch A, Moreau NM, Uleryk E, Doria AS, Radiology 2006 241 854 860 10.1148/radiol.2413051358 17053199 (Pubitemid 46190553)
35. Association between compliance with methodological standards of diagnostic research and reported test accuracy: meta-analysis of focused assessment of US for trauma. Stengel D, Bauwens K, Rademacher G, Mutze S, Ekkernkamp A, Radiology 2005 236 102 111 10.1148/radiol.2361040791 15983072 (Pubitemid 40853301)
36. Analysis of the quality of reporting of randomized controlled trials in acute and chronic myeloid leukemia, and myelodysplastic syndromes as governed by the CONSORT statement. Ziogas DC, Zintzaras E, Ann Epidemiol 2009 19 494 500 10.1016/j.annepidem.2009.03.018 19523596